Cargando…
Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
Autores principales: | Rashid, Nazia, Saenger, Paul, Wu, Yi-Lin, Woehling, Heike, Frankel, Matthew, Lifshitz, Fima, Muenzberg, Michael, Rapaport, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254864/ https://www.ncbi.nlm.nih.gov/pubmed/25407940 http://dx.doi.org/10.1007/s13554-014-0020-6 |
Ejemplares similares
-
Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
por: Rashid, Nazia, et al.
Publicado: (2014) -
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
por: Rapaport, Robert, et al.
Publicado: (2013) -
Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden
por: Flodmark, Carl-Erik, et al.
Publicado: (2013) -
Exogenous recombinant human growth hormone effects during suboptimal energy and zinc intake
por: Rising, Russell, et al.
Publicado: (2005) -
Erratum: Involvement of hormones in olfactory imprinting and homing in chum salmon
por: Ueda, Hiroshi, et al.
Publicado: (2016)